Latest News and Press Releases
Want to stay updated on the latest news?
-
CAMBRIDGE, Mass., Jan. 7, 2011 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) today provided guidance on its anticipated pipeline and business goals for 2011. Infinity begins the...
-
CAMBRIDGE, Mass., Jan. 5, 2011 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) will be presenting at the J.P. Morgan 29th Annual Healthcare Conference on Thursday, January 13, 2011 at...
-
CAMBRIDGE, Mass., Jan. 3, 2011 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) announces that, effective today, it has been named to the NASDAQ Global Select Market tier, the premier...
-
Mundipharma Commits to Providing Up to $110 Million in R&D Funding for 2012 in Addition to $85 Million Previously Committed for 2011 Companies Agree Upon Event-Based Approach for IPI-926...
-
CAMBRIDGE, Mass., Nov. 22, 2010 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) will be presenting at the Piper Jaffray 22nd Annual "Unplugged" Health Care Conference on Wednesday,...
-
Ongoing Clinical Trial Evaluating a New Approach for Pancreatic Cancer, One of the Most Difficult to Treat Cancers Spotlight on Pancreatic Cancer Awareness Month in November DENVER, Nov. 16,...
-
– Ongoing Clinical Trial Evaluating a New Approach for Pancreatic Cancer, One of the Most Difficult to Treat Cancers – – Spotlight on Pancreatic...
-
Ongoing Clinical Trial Evaluating a New Approach for Pancreatic Cancer, One of the Most Difficult to Treat Cancers Spotlight on Pancreatic Cancer Awareness Month in November DALLAS, Nov. 15,...
-
CAMBRIDGE, Mass., Nov. 10, 2010 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) will be presenting at the Lazard Capital Markets 7th Annual Healthcare Conference on Wednesday,...
-
CAMBRIDGE, Mass., Nov. 9, 2010 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) today highlighted its recent business and clinical progress, and announced third quarter 2010 financial...